FDA NDC Directory · JSON-LD · Markdown

BENLYSTA

NDC 49401-102 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namebelimumab
Labeler / ManufacturerGlaxoSmithKline LLC
Marketing categoryBiologic License Application · App BLA125370
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsBELIMUMAB (400 mg/5mL)
Marketing started20110310
Package count1

External sources

Source: openFDA. Public-domain (CC0).